Brazil to develop its own dengue vaccine to release in 2018

Published On 2015-08-15 06:47 GMT   |   Update On 2015-08-15 06:47 GMT
Brazil’s own dengue vaccine is currently under progression, and will be ready for release in 2018, as confirmed by IANS. The vaccine is going through various tests, and once the procedure is completed, it will be made available in 2018.

The biomedical research centres -- the Butantan Institute in Sao Paulo and the Fiocruz in Rio de Janeiro -- are currently carrying out the tests.

"We are currently hoping for a safe vaccine against dengue to be developed fully... At best we will have the vaccine in 2018," Xinhua quoted Brazil's Health Minister Artur Chioro as saying on Thursday.

The Butantan Institute last week received approval from the National Technical Commission for Biosecurity (CTNBio) to begin the vaccination's third phase of clinical studies.

Brazil has also seen a sharp rise in the incidence of dengue with the number of cases rising to 746,000 cases this year
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News